Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Ryo Hisada, Ph.D., M.D.


Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Umeda M, Yoshida N, Hisada R, Burbano C, Orite SYK, Kono M, Kyttaris VC, Krishfield S, Owen CA, Tsokos GC. ADAM9 enhances Th17 cell differentiation and autoimmunity by activating TGF-ß1. Proc Natl Acad Sci U S A. 2021 May 04; 118(18). PMID: 33911034.
    Citations:    Fields:    
  2. Fujieda Y, Doi M, Asaka T, Ota M, Hisada R, Ohnishi N, Kono M, Kameda H, Nakazawa D, Kato M, Amengual O, Takahata M, Yasuda S, Kitagawa Y, Atsumi T. Incidence and risk of antiresorptive agent-related osteonecrosis of the jaw (ARONJ) after tooth extraction in patients with autoimmune disease. J Bone Miner Metab. 2020 Jul; 38(4):581-588. PMID: 32076874.
    Citations: 1     Fields:    Translation:Humans
  3. Nakamura H, Fujieda Y, Tarumi M, Kitakawa H, Hisada R, Nakagawa I, Noguchi A, Kurita T, Kataoka H, Kasahara H, Amasaki Y, Yokota I, Atsumi T. Calcineurin inhibitors for adult-onset Still's disease: a multicentre retrospective cohort study. Clin Exp Rheumatol. 2020 Sep-Oct; 38 Suppl 127(5):11-16. PMID: 32083551.
    Citations:    Fields:    Translation:Humans
  4. Sugawara E, Kato M, Kudo Y, Lee W, Hisada R, Fujieda Y, Oku K, Bohgaki T, Amengual O, Yasuda S, Onodera T, Hatakeyama S, Atsumi T. Autophagy promotes citrullination of VIM (vimentin) and its interaction with major histocompatibility complex class II in synovial fibroblasts. Autophagy. 2020 05; 16(5):946-955. PMID: 31486697.
    Citations: 5     Fields:    Translation:HumansCells
  5. Ohnishi N, Fujieda Y, Hisada R, Nakamura H, Kato M, Oku K, Bohgaki T, Amengual O, Yasuda S, Atsumi T. Efficacy of dual antiplatelet therapy for preventing recurrence of arterial thrombosis in patients with antiphospholipid syndrome. Rheumatology (Oxford). 2019 06 01; 58(6):969-974. PMID: 30508199.
    Citations: 4     Fields:    Translation:HumansPHPublic Health
  6. Ohmura K, Oku K, Kitaori T, Amengual O, Hisada R, Kanda M, Shimizu Y, Fujieda Y, Kato M, Bohgaki T, Horita T, Yasuda S, Sugiura-Ogasawara M, Atsumi T. Pathogenic roles of anti-C1q antibodies in recurrent pregnancy loss. Clin Immunol. 2019 06; 203:37-44. PMID: 30974291.
    Citations: 4     Fields:    Translation:HumansAnimalsCells
  7. Hisada R, Kato M, Ohnishi N, Sugawara E, Fujieda Y, Oku K, Bohgaki T, Amengual O, Yasuda S, Atsumi T. Antiphospholipid score is a novel risk factor for idiopathic osteonecrosis of the femoral head in patients with systemic lupus erythematosus. Rheumatology (Oxford). 2019 04 01; 58(4):645-649. PMID: 30521019.
    Citations: 3     Fields:    Translation:Humans
  8. Hisada R, Kato M, Sugawara E, Kanda M, Fujieda Y, Oku K, Bohgaki T, Amengual O, Horita T, Yasuda S, Atsumi T. Circulating plasmablasts contribute to antiphospholipid antibody production, associated with type I interferon upregulation. J Thromb Haemost. 2019 07; 17(7):1134-1143. PMID: 30864219.
    Citations: 3     Fields:    Translation:HumansCells
  9. Noguchi A, Yasuda S, Hisada R, Kato M, Oku K, Bohgaki T, Suzuki M, Matsumoto Y, Atsumi T. Anti-cyclic citrullinated peptide antibody titers decrease in rheumatoid arthritis patients treated with tocilizumab: A pilot study. Mod Rheumatol. 2020 Mar; 30(2):276-281. PMID: 30789096.
    Citations: 1     Fields:    Translation:Humans
  10. Kato M, Hisada R, Atsumi T. Clinical profiles and risk assessment in patients with antiphospholipid antibodies. Expert Rev Clin Immunol. 2019 01; 15(1):73-81. PMID: 30381978.
    Citations: 4     Fields:    Translation:HumansPHPublic Health
  11. Tanimura S, Fujieda Y, Kono M, Shibata Y, Hisada R, Sugawara E, Nakamura H, Ohmura K, Shimamura S, Mitani A, Shida H, Watanabe T, Kato M, Oku K, Bohgaki T, Amengual O, Yasuda S, Shimizu C, Atsumi T. Clinical significance of plasma presepsin levels in patients with systemic lupus erythematosus. Mod Rheumatol. 2018 Sep; 28(5):865-871. PMID: 29239264.
    Citations: 1     Fields:    Translation:Humans
  12. Hisada R, Kato M, Sugawara E, Fujieda Y, Oku K, Bohgaki T, Amengual O, Yasuda S, Atsumi T. Thrombotic risk stratification by platelet count in patients with antiphospholipid antibodies: a longitudinal study. J Thromb Haemost. 2017 09; 15(9):1782-1787. PMID: 28662299.
    Citations: 8     Fields:    Translation:HumansCells
  13. Watanabe T, Oku K, Amengual O, Hisada R, Ohmura K, Nakagawa I, Shida H, Bohgaki T, Horita T, Yasuda S, Atsumi T. Effects of statins on thrombosis development in patients with systemic lupus erythematosus and antiphospholipid antibodies. Lupus. 2018 Feb; 27(2):225-234. PMID: 28659045.
    Citations: 5     Fields:    Translation:Humans
  14. Sugawara E, Kato M, Hisada R, Oku K, Bohgaki T, Horita T, Yasuda S, Atsumi T. Treatment of Vasodilator-resistant Mixed Connective Tissue Disease-associated Pulmonary Arterial Hypertension with Glucocorticoid and Cyclophosphamide. Intern Med. 2017; 56(4):445-448. PMID: 28202869.
    Citations: 1     Fields:    Translation:Humans
  15. Oku K, Amengual O, Hisada R, Ohmura K, Nakagawa I, Watanabe T, Bohgaki T, Horita T, Yasuda S, Atsumi T. Autoantibodies against a complement component 1 q subcomponent contribute to complement activation and recurrent thrombosis/pregnancy morbidity in anti-phospholipid syndrome. Rheumatology (Oxford). 2016 08; 55(8):1403-11. PMID: 27084309.
    Citations: 7     Fields:    Translation:Humans
  16. Shimizu Y, Yasuda S, Kako Y, Nakagawa S, Kanda M, Hisada R, Ohmura K, Shimamura S, Shida H, Fujieda Y, Kato M, Oku K, Bohgaki T, Horita T, Kusumi I, Atsumi T. Post-steroid neuropsychiatric manifestations are significantly more frequent in SLE compared with other systemic autoimmune diseases and predict better prognosis compared with de novo neuropsychiatric SLE. Autoimmun Rev. 2016 Aug; 15(8):786-94. PMID: 27016478.
    Citations: 4     Fields:    Translation:Humans
  17. Oku K, Amengual O, Hisada R, Oomura K, Nakagawa I, Watanabe T, Bohgaki T, Horita T, Yasuda S, Atsumi T. [The function and the significance of full-automated tests for detecting antiphospholipid antibodies]. Nihon Rinsho Meneki Gakkai Kaishi. 2015; 38(3):157-63. PMID: 26213194.
    Citations:    Fields:    Translation:Humans
  18. Jodo S, Hisada R. Giant cell arteritis. Nihon Rinsho Meneki Gakkai Kaishi. 2013; 36(6):459-66. PMID: 24390106.
    Citations:    Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Hisada's Networks
Click the
buttons for more information and interactive visualizations!
Concepts (104)
Co-Authors (5)
Similar People (60)
Same Department 
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.